Global Autoimmune Disease Diagnostics Market 2017-2021

Global Autoimmune Disease Diagnostics Market 2017-2021

Category : Diagnostic and Biotech
Published On : September  2016
Pages : 134



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About the Autoimmune Disease Diagnostics Market
 
Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.
 
Technavio’s analysts forecast the global autoimmune disease diagnostics market to grow at a CAGR of 6.39% during the period 2017-2021.
 
Covered in this report 
The report covers the present scenario and the growth prospects of the global autoimmune disease diagnostics market for 2017-2021. To calculate the market size, we use the revenue generated from the sales of various diagnostic tests for autoimmune diseases.
 
The market is divided into the following segments based on geography: 
• Americas
• APAC
• EMEA
 
Technavio's report, Global Autoimmune Disease Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 
 
Key vendors 
• Abbott Laboratories
• Beckman Coulter
• Bio-Rad Laboratories
• Inova Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific
 
Other prominent vendors 
• AESKU Diagnostics 
• Alere
• Autoimmune Technologies
• Bio-Diagnostics 
• bioMérieux 
• Diarect 
• DiaSorin
• Erba Diagnostics
•  Euro Diagnostica 
• EUROIMMUN 
• Exagen Diagnostics
• Gold Standard Diagnostics
• HUMAN Diagnostics 
• ImmunArray
•  KRONUS  
• Menarini  
• Myriad Genetics
• Omega Diagnostics
• ORGENTEC Diagnostika
• Protagen
• Qiagen  
• Quest Diagnostics
• Roche Diagnostics
• Seramun Diagnostica 
• SQI Diagnostics 
• Tecan
 
Market driver 
• Discovery of novel biomarkers 
• For a full, detailed list, view our report 
 
Market challenge 
• Lack of skilled laboratory technicians
• For a full, detailed list, view our report 
 
Market trend 
• Shift from monoplex to multiplex testing
• For a full, detailed list, view our report 
 
Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors? 
 
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Autoimmune diseases
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Market segmentation by disease type
• Systemic autoimmune disease diagnostics
• Global systemic autoimmune disease market overview
• Localized autoimmune disease diagnostics
• Global localized autoimmune disease diagnostics market overview
PART 07: Market segmentation by product type
• Analyzers
• Global autoimmune diseases analyzers market overview
• Assay kits
• Global autoimmune disease assay kits market overview
PART 08: Market segmentation by test type
• ANA tests
• CRP
• Urinalysis test
• ESR
• CMP test
• Other
PART 09: Market segmentation by end-user
• Hospitals
• Diagnostic and research laboratories
PART 10: Geographical segmentation
• Autoimmune disease diagnostics market in Americas
• Autoimmune disease diagnostics market in EMEA
• Autoimmune disease diagnostics market in APAC
PART 11: Market drivers
• Discovery of novel biomarkers leading to improved autoimmune diagnosis
• Advancements in laboratory automation platforms
• Increasing M&A
• Product approvals and launches
PART 12: Impact of drivers
PART 13: Market challenges
• Limitation of autoimmune disease diagnostics
• Significant concerns over standardization and quality of immunoassay kits
• Lack of understanding on the basic etiology of several autoimmune diseases
• Shortage of skilled technicians for performing diagnostic assays
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Focus on companion diagnostic tests
• Shift from monoplex to multiplex testing
• Collaboration between pharma and diagnostic companies
• Growing consumer shift toward direct-to-consumer testing
PART 16: Vendor landscape
• Competitive scenario
• Key news
• Vendors market share 2015
PART 17: Key vendor analysis
• Abbott Laboratories
• Beckman Coulter
• Bio-Rad Laboratories
• EUROIMMUN
• Inova Diagnostics
• Roche Diagnostics
• Siemens Healthcare
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
?




Exhibit 01: Product offerings
Exhibit 02: Etiology of autoimmune diseases
Exhibit 03: Signs and symptoms of autoimmune diseases
Exhibit 04: Average annual treatment cost of RA in US and Europe 2014 ($ billions)
Exhibit 05: Average annual treatment costs of multiple sclerosis across countries 2014 ($ billions)
Exhibit 06: Snapshot of global autoimmune disease diagnostics market 2016-2021
Exhibit 07: Global autoimmune disease diagnostics market snapshot
Exhibit 08: Key trends in global autoimmune disease diagnostics market
Exhibit 09: Global autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 10: Opportunity analysis in developed and emerging markets
Exhibit 11: Opportunity analysis of global autoimmune diagnostics market
Exhibit 12: Five forces analysis
Exhibit 13: Global autoimmune disease diagnostics market segmentation by disease type
Exhibit 14: Global systemic autoimmune disease diagnostics market 2016
Exhibit 15: Global localized autoimmune disease diagnostics market 2016
Exhibit 16: Global autoimmune disease diagnostics market segmentation by disease type 2016
Exhibit 17: Global autoimmune disease diagnostics market segmentation by disease type 2016
Exhibit 18: Antibodies for diagnosis of different systemic autoimmune diseases
Exhibit 19: Global systemic autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 20: Global RA diagnostics market 2016-2021 ($ millions)
Exhibit 21: Prevalence and incidence of SLE
Exhibit 22: Global SLE diagnostics market overview 2016-2021 ($ millions)
Exhibit 23: Global systemic autoimmune disease diagnostics market measurement parameters
Exhibit 24: Opportunity analysis of systemic autoimmune disease market
Exhibit 25: Antibodies used for diagnosis of different localized autoimmune diseases
Exhibit 26: Global localized autoimmune disease diagnostics market 2016-2021 ($ millions)
Exhibit 27: Opportunity analysis of localized autoimmune disease diagnostics market
Exhibit 28: Global type 1 diabetes diagnostics market 2016-2021 ($ millions)
Exhibit 29: Global autoimmune thyroiditis diagnostics market 2016-2021 ($ millions)
Exhibit 30: Global localized autoimmune disease diagnostics market measurement parameters
Exhibit 31: Global autoimmune disease diagnostics market segmentation by disease type 2016-2021 ($ millions)
Exhibit 32: Global autoimmune disease diagnostics market segmentation by disease type 2016-2021
Exhibit 33: Analysis of autoimmune disease diagnostics market segmentation by disease type
Exhibit 34: Global autoimmune disease diagnostics market segmentation by product type
Exhibit 35: Global autoimmune disease diagnostics market segmentation by product type 2016-2021
Exhibit 36: Global autoimmune disease diagnostics market segmentation by product type 2016
Exhibit 37: Global autoimmune disease diagnostics market segmentation by product type 2016
Exhibit 38: Some of the analyzers developed by vendors
Exhibit 39: Global autoimmune diseases analyzers market 2016-2021 ($ millions)
Exhibit 40: Opportunity analysis of autoimmune disease analyzers market
Exhibit 41: Some of the assays kits available in the market
Exhibit 42: Some of the key news related to assay kits
Exhibit 43: Global autoimmune diseases assay kits market 2016-2021 ($ millions)
Exhibit 44: Opportunity analysis for autoimmune disease assay kits
Exhibit 45: Analysis of autoimmune disease diagnostics market by product type
Exhibit 46: Global autoimmune disease diagnostics market by product type 2016-2021 ($ millions)
Exhibit 47: Global autoimmune disease diagnostics market by product type 2016-2021
Exhibit 48: Global autoimmune disease diagnostics market segmentation by test type
Exhibit 49: Global autoimmune disease diagnostics market segmentation by test type
Exhibit 50: Some of the examples of ANA tests
Exhibit 51: Global autoimmune disease diagnostics market segmentation by geography 2016-2021
Exhibit 52: Global autoimmune disease diagnostics market segmentation by geography 2016
Exhibit 53: Global autoimmune disease diagnostics market segmentation by geography 2016
Exhibit 54: Global autoimmune disease diagnostics market segmentation by geography 2016-2021 ($ millions)
Exhibit 55: Global autoimmune disease diagnostics market segmentation by geography 2016-2021
Exhibit 56: Americas: Market overview of autoimmune disease diagnostics
Exhibit 57: Comparison of US healthcare system: Before and after reforms
Exhibit 58: Autoimmune disease diagnostics market in Americas 2016-2021 ($ millions)
Exhibit 59: Autoimmune disease diagnostics market in EMEA 2016-2021 ($ millions)
Exhibit 60: EMEA: Market overview of autoimmune disease diagnostics
Exhibit 61: APAC: Market overview of autoimmune disease diagnostics
Exhibit 62: Autoimmune disease diagnostics market in APAC 2016-2021 ($ millions)
Exhibit 63: Key initiatives of vendors fueling the launch of novel biomarkers
Exhibit 64: Key highlights of laboratory automation
Exhibit 65: Some of the consolidations witnessed during 2015-2016
Exhibit 66: Impact of drivers
Exhibit 67: Force field analysis of global autoimmune disease diagnostics market
Exhibit 68: Impact of drivers and challenges
Exhibit 69: Impact of trends on global autoimmune disease diagnostics market
Exhibit 70: Vendors' product development strategy for end-users
Exhibit 71: Competitive structure analysis of global autoimmune diagnostics market 2017-2021
Exhibit 72: Strategic success factors for companies in global autoimmune disease diagnostics market
Exhibit 73: Market penetration analysis of key vendors in autoimmune disease diagnostics 2015
Exhibit 74: Vendors' market share breakdown 2015
Exhibit 75: Abbott Laboratories: Profile
Exhibit 76: Abbott Laboratories: Strength assessment
Exhibit 77: Abbott Laboratories: Strategy assessment
Exhibit 78: Abbott Laboratories: Opportunity assessment
Exhibit 79: Beckman Coulter: Key highlights
Exhibit 80: Beckman Coulter: Strength assessment
Exhibit 81: Beckman Coulter: Strategy assessment
Exhibit 82: Beckman Coulter: Opportunity assessment
Exhibit 83: Bio-Rad Laboratories: Key highlights
Exhibit 84: Bio-Rad Laboratories: Strength assessment
Exhibit 85: Bio-Rad Laboratories: Strategy assessment
Exhibit 86: Bio-Rad Laboratories: Opportunity assessment
Exhibit 87: EUROIMMUN: Profile
Exhibit 88: EUROIMMUN: Strength assessment
Exhibit 89: EUROIMMUN: Strategy assessment
Exhibit 90: EUROIMMUN: Opportunity assessment
Exhibit 91: Inova Diagnostics: Key highlights
Exhibit 92: Inova Diagnostics: Strength assessment
Exhibit 93: Inova Diagnostics: Strategy assessment
Exhibit 94: Inova Diagnostics: Opportunity assessment
Exhibit 95: Roche Diagnostics: Key highlights
Exhibit 96: Roche Diagnostics: Strength assessment
Exhibit 97: Roche Diagnostics: Strategy assessment
Exhibit 98: Roche Diagnostics: Opportunity assessment
Exhibit 99: Siemens Healthcare: Key highlights
Exhibit 100: Siemens Healthcare: Strength assessment
Exhibit 101: Siemens Healthcare: Strategy assessment
Exhibit 102: Siemens Healthcare: Opportunity assessment

Enquiry Before Buy
image
Can´t read the image ? refresh here.